Literature DB >> 12767899

TNF-related weak inducer of apoptosis receptor, a TNF receptor superfamily member, activates NF-kappa B through TNF receptor-associated factors.

Songyi Han1, Kwiyeom Yoon, Kyunghye Lee, Kyunghee Kim, Hyunduk Jang, Na Kyung Lee, Kichul Hwang, Soo Young Lee.   

Abstract

TNF-related weak inducer of apoptosis (TWEAK) is a member of the TNF ligand family that induces angiogenesis in vivo. The TWEAK receptor (TweakR) is a recently identified member of the TNF receptor (TNFR) superfamily and is expressed on smooth muscle cells (SMCs) and endothelial cells (ECs). In this report we identify the TNF receptor-associated factor (TRAF) family of signal transducers as important components of TweakR-mediated NF-kappa B activation. Coimmunoprecipitation experiments suggested potential interactions between the cytoplasmic tail of TweakR with TRAFs 1, 2, 3, and 5. Dominant negative forms of TRAF2 and TRAF5 substantially inhibited TweakR-mediated NF-kappa B activation, suggesting a role of TRAFs in regulating smooth muscle and endothelial cell function. Using alanine-scanning analysis, we defined a TRAF-binding motif, PIEET, in TweakR that mediates TRAF binding and NF-kappa B activation. Furthermore, TweakR mutations within the TRAF-binding motif abolished TweakR-stimulated SMC migration, revealing a role for TRAFs in TweakR-induced activation events.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12767899     DOI: 10.1016/s0006-291x(03)00852-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

Review 1.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

2.  Fibroblast growth factor-inducible 14 mediates macrophage infiltration in heart to promote pressure overload-induced cardiac dysfunction.

Authors:  Sathya D Unudurthi; Drew M Nassal; Nehal J Patel; Evelyn Thomas; Jane Yu; Curtis G Pierson; Shyam S Bansal; Peter J Mohler; Thomas J Hund
Journal:  Life Sci       Date:  2020-02-15       Impact factor: 5.037

3.  Regulation of fibroblast growth factor-inducible 14 (Fn14) expression levels via ligand-independent lysosomal degradation.

Authors:  Sujatha Gurunathan; Jeffrey A Winkles; Sankar Ghosh; Matthew S Hayden
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

4.  Biomeasures and mechanistic modeling highlight PK/PD risks for a monoclonal antibody targeting Fn14 in kidney disease.

Authors:  Xiaoying Chen; Vahid Farrokhi; Pratap Singh; Mireia Fernandez Ocana; Jenil Patel; Lih-Ling Lin; Hendrik Neubert; Joanne Brodfuehrer
Journal:  MAbs       Date:  2017-11-30       Impact factor: 5.857

5.  The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.

Authors:  Hengdao Liu; Dan Lin; Hong Xiang; Wei Chen; Shaoli Zhao; Hui Peng; Jie Yang; Pan Chen; Shuhua Chen; Hongwei Lu
Journal:  Exp Ther Med       Date:  2017-06-14       Impact factor: 2.447

6.  Therapeutic potential of the TWEAK/Fn14 pathway in intractable gastrointestinal cancer.

Authors:  Ryo Yoriki; Satoru Akashi; Masayuki Sho; Takeo Nomi; Ichiro Yamato; Kiyohiko Hotta; Tomoyoshi Takayama; Sohei Matsumoto; Kohei Wakatsuki; Kazuhiro Migita; Hideo Yagita; Yoshiyuki Nakajima
Journal:  Exp Ther Med       Date:  2010-12-02       Impact factor: 2.447

7.  Multi-gene targeted antiangiogenic therapies for experimental corneal neovascularization.

Authors:  Peng Chen; Hongmei Yin; Yao Wang; Jing Mi; Wenxiao He; Lixin Xie; Yiqiang Wang
Journal:  Mol Vis       Date:  2010-02-27       Impact factor: 2.367

8.  The cytokine TWEAK modulates renal tubulointerstitial inflammation.

Authors:  Ana Belen Sanz; Pilar Justo; Maria Dolores Sanchez-Niño; Luis Miguel Blanco-Colio; Jeffrey A Winkles; Matthias Kreztler; Aniela Jakubowski; Julia Blanco; Jesús Egido; Marta Ruiz-Ortega; Alberto Ortiz
Journal:  J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 10.121

Review 9.  TWEAK and the central nervous system.

Authors:  Manuel Yepes
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

Review 10.  The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.

Authors:  Jeffrey A Winkles
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.